Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0113 | 0.0463 | 0.8342 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0113 | 0.0463 | 0.8342 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0125 | 0.0555 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0113 | 0.0463 | 0.8342 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0125 | 0.0555 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0432 | 0.2801 | 0.2801 |
Schistosoma mansoni | hypothetical protein | 0.1414 | 1 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0913 | 0.6324 | 0.6008 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0113 | 0.0463 | 0.8342 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0113 | 0.0463 | 0.8342 |
Echinococcus multilocularis | small conductance calcium activated potassium | 0.1414 | 1 | 1 |
Brugia malayi | glutathione reductase | 0.0049 | 0 | 0.5 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0125 | 0.0555 | 1 |
Leishmania major | trypanothione reductase | 0.0049 | 0 | 0.5 |
Trypanosoma brucei | trypanothione reductase | 0.0049 | 0 | 0.5 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0846 | 0.5837 | 0.5837 |
Schistosoma mansoni | calcium-activated potassium channel | 0.1414 | 1 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0049 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0481 | 0.3162 | 0.3162 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0049 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0455 | 0.2972 | 0.2972 |
Toxoplasma gondii | thioredoxin reductase | 0.0049 | 0 | 0.5 |
Plasmodium falciparum | thioredoxin reductase | 0.0049 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1414 | 1 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0049 | 0 | 0.5 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0049 | 0 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0049 | 0 | 0.5 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0125 | 0.0555 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0113 | 0.0463 | 0.8342 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.